The signing of the 21st Century Cures Act in 2016 was a long-awaited milestone for interoperability in healthcare—yet with so many regulations and other key details left to be determined after the fact, 2023 was when interoperability’s true promise finally began to emerge. Here are three key updates for payers to track as the Trusted Exchange Framework and Common Agreement (TEFCA), which was established by the Cures Act, comes to life in 2024.
This long-awaited rule finalized by the Centers for Medicare & Medicaid Services (CMS) in January requires Medicare Advantage plans, Medicaid plans, and other federally funded payers to implement FHIR-based application programming interfaces (APIs) to improve the electronic exchange of healthcare data while also expediting prior authorization processes. These APIs must support payer-to-payer access, provider access, direct patient access, and prior authorization, with a deadline of January 1, 2027.
What it means for payers: The clock is ticking for payers covered by this rule. Payers will now have to communicate the approval or denial of a prior authorization request, or the request for more information. Information about prior authorizations must be included in the data available via the patient access API. In addition, payers will be required to share patient claims and encounter data with in-network providers with whom the patient has a treatment relationship. This same information must be shared for improved continuity of care when a patient changes health plans.
Five Qualified Health Information Networks (QHINs) have now completed the TEFCA onboarding process and can now support FHIR-based data exchange under the Common Agreement, version 2 of which was released in January. Until this point, there was ambiguity regarding the timelines to support exchange purposes outside of treatment and public health, which made it difficult for payers and their business associates to plan their interoperability strategies around use cases such as payment integrity, quality improvement, and risk adjustment. However, version 2 provides a carve-out for payers and their delegates to participate in QHIN data exchange.
What it means for payers: By joining a QHIN, payers and their healthcare analytics partners like Cotiviti can dramatically improve the amount of digital information acquired through a single point connection. Instead of contracting with a patchwork of providers individually and dealing with proprietary formats, payers can now access high-quality clinical data at scale.
In mid-2023, the Office of Inspector General (OIG) published its final information blocking rule, implementing a $1 million penalty per violation for entities that commit information blocking, which is defined as practices are “likely to interfere with the access, exchange, or use of electronic health information (EHI), except as required by law or specified in an information blocking exception.” This applies to health IT developers as well as health information exchanges. HHS followed this with a proposed rule to establish disincentives that would apply to providers and health systems.
What it means for payers: As noted by guidance from the American Medical Association, providers who block payers from seeking EHI to confirm a clinical value could be at high risk of committing an information blocking violation. The implementation of these information blocking rules is a highly promising development that could reduce the abrasion that can result from payers seeking medical records to support their payment integrity, risk adjustment, and quality improvement programs.
As additional rules are finalized and timelines emerge, payers should consider these steps to position themselves for interoperability success in 2024.
Learn more about interoperability updates from our on-demand RISE webinar offering key risk adjustment trends to watch in 2024 and beyond. Our seasoned risk adjustment experts unravel trends, impact and opportunities for healthcare organizations, and sustainable innovations to help adapt to key industry and regulatory shifts.
You'll learn more about: